18.01.2015 Views

guidebook. - Fanconi Anemia Research Fund

guidebook. - Fanconi Anemia Research Fund

guidebook. - Fanconi Anemia Research Fund

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

28<br />

<strong>Fanconi</strong> <strong>Anemia</strong>: Guidelines for Diagnosis and Management<br />

▫▫<br />

Post-Transplant Care<br />

The related donor must be tested to rule<br />

out <strong>Fanconi</strong> anemia.<br />

• Schedule of post-transplant clinical examinations:<br />

See Table 2 in Chapter 11 (Late Effects in<br />

<strong>Fanconi</strong> <strong>Anemia</strong> Patients Post-transplant) for<br />

schedule of post-transplant clinical examinations.<br />

• Early complications: Watch for early complications<br />

of transplant, such as GvHD, graft failure,<br />

organ toxicity, and infections. Provide close<br />

follow-up of rashes, diarrhea, liver enzymes,<br />

and blood counts, with testing for viruses and<br />

monitoring of drug levels.<br />

• Late complications:<br />

▫▫<br />

Monitor for chronic GvHD, organ<br />

toxicity (cardiac, pulmonary, renal) or<br />

endocrinopathies (diabetes, hypothyroidism,<br />

gonadal dysfunction), osteoporosis,<br />

avascular necrosis, and cancer, particularly<br />

HNSCC.<br />

• Infectious disease prophylaxis post-HSCT<br />

(yeast/fungal; viral; protozoal):<br />

▫▫<br />

Most transplant centers will expect the<br />

patient to remain near the facility for a<br />

minimum of 100 days, the highest risk<br />

period for the development of the immunologic<br />

complications (i.e., graft rejection,<br />

GvHD, and opportunistic infection)<br />

associated with transplantation. Prophylactic<br />

antibiotic regimens commonly<br />

used after HSCT are outlined in Chapter<br />

10 (Unrelated Donor HSCT).

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!